MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with T

Trimetazidine

Trimetazidine 20mg tablets

No stability information

Stability notes for Trimetazidine 20mg tablets

There are no stability notes for this medicine.

Suppliers

Trimetazidine 20mg tablets (Special Order)
Vastarel 20mg tablets (Imported (France))

Trimetazidine 35mg modified-release tablets

No stability information

Stability notes for Trimetazidine 35mg modified-release tablets

There are no stability notes for this medicine.

Suppliers

Trimetazidine 35mg modified-release tablets (Part VIIID Drug Tariff Special Order)
Vastarel MR 35mg tablets (Imported (France))

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.